A/Prof Maté Biro (UNSW Sydney) combines his expertise in cellular biology and advanced microscopy to improve cancer treatment efficacy, paving the way for next-generation therapies that could revolutionise the fight against cancer.
In 2023, A/Prof Maté Biro (UNSW Sydney) developed a ground-breaking technology to guide cancer-fighting cells directly to tumours.
Through his spin-out, synPair Biosciences, he is creating safe synthetic homing signals that direct immune cells used in cell therapies to specific tissues or organs, overcoming a major barrier in treating solid cancers by ensuring enough cells infiltrate tumours.
A/Prof Biro, whose nine-year term as an EMBL Australia group leader recently concluded, leverages advanced microscopy to study how the actin cytoskeleton drives tumour cell invasion and immune cell movement, aiming to uncover fundamental processes and develop innovative research methods.
Read more case studies on EMBL Australia group leaders in our Impact Report.